Novo Nordisk has pulled ahead in the race to bring the first oral GLP-1 for obesity to market. The company announced Friday ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Several male enhancement dietary supplements have been recalled due to undeclared and potentially harmful ingredients being ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

You’ve probably been there — staring at another diet plan, another gym ad, another promise of results. And if you’ve ever ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity treatment more than tripled among US adults without diabetes between 2018 and ...

Speaking at Berkshire's annual meeting in Omaha, Buffett Says Greg Abel Should Succeed at Year-End. Auto lenders tightened lending in recent years after the pandemic car-buying frenzy.

Our writer explains why he just added to a big loser to his Stocks and Shares ISA portfolio, despite it going against one of ...

Pop quiz: would you prefer to take a medication as a pill or inject yourself with it? Somehow, I suspect that the vast ...